Lung June 2007 - Updates from ASCO 2007

We would like to thank Drs Charles Butts, Ron Burkes & Randeep Sangha for providing us with the latest oncology lung conference updates

ASCO 2007 Conference Updates

A Randomized, double-blind phase III study of Bevacizumab in combination with cisplatin and gemcitabine in chemotherapy-naïve patients with advancedor recurrent non-squamous NSCL cancer (AVAiL)

Phase III trial of cisplatin (P) plus etoposide (E) plus concurrent chest radiation (XRT) with or without consolidation docetaxel (D) in patients with inoperable stage III non-small cell lung cancer (NSCLC): HOG LUN 01-24/USO-023

A Randomized trial of prophylactic cranial irradiation (PCI) versus no PCI in extensive disease small cell lung cancer after a response to chemotherapy (EORTC 08993-22993)

Outcomes for elderly NSCL cancer patients treated with Bevacizumab (B) and carboplatin/paclitaxel: Analysis of the ECOG 4599 Trial

Phase III study of Gefitinib vs Docetaxel in Japanese Patients with NSCLC who Failed 1 or 2 Chemotherapy Regimens

Phase III study of Immediate Versus Delayed Docetaxel after Induction Therapy with Gemcitabine Plus Carboplatin in Advanced Non-Small Cell Lung Cancer